Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire December 01, 2025 CHARLESTOWN, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 23,284 restricted stock units (“RSUs”) to two newly hired […]

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire December 01, 2025 CAMBRIDGE, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) — Akebia Therapeutics(R), Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted two newly-hired employees options to purchase an aggregate of 22,576 shares

XPO Provides North American LTL Operating Data for November 2025

XPO Provides North American LTL Operating Data for November 2025 GlobeNewswire December 01, 2025 GREENWICH, Conn., Dec. 01, 2025 (GLOBE NEWSWIRE) — XPO (NYSE: XPO), a leading provider of freight transportation in North America, today reported certain preliminary LTL segment operating metrics for November 2025. LTL tonnage per day decreased 5.4%, as compared with November

Announcement relating to convening of Scheme Meeting and Extraordinary General Meeting

Announcement relating to convening of Scheme Meeting and Extraordinary General Meeting GlobeNewswire December 01, 2025 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. THIS IS AN ANNOUNCEMENT MADE UNDER

ACM Research Announces Participation in 14th Annual NYC Summit

ACM Research Announces Participation in 14th Annual NYC Summit GlobeNewswire December 01, 2025 FREMONT, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) — ACM Research, Inc. (“ACM”) (NASDAQ: ACMR), a leading supplier of wafer and panel processing solutions for semiconductor and advanced packaging applications, today announced that it will be joining 14 other companies in collectively hosting

Alector to Participate in the Bank of America CNS Therapeutics Conference

Alector to Participate in the Bank of America CNS Therapeutics Conference GlobeNewswire December 01, 2025 SOUTH SAN FRANCISCO, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced that management will participate in a fireside chat at

Jewett-Cameron Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results

Jewett-Cameron Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results GlobeNewswire December 01, 2025 Company to host webcast today, December 1, 2025, at 4:30 p.m. Eastern time NORTH PLAINS, Ore., Dec. 01, 2025 (GLOBE NEWSWIRE) — Jewett-Cameron Trading Company Ltd. (the “Company”; Nasdaq: JCTC), a company committed to innovative products that enrich

Superior Group of Companies to Participate in Noble Capital Markets’ 21st Annual Emerging Growth Equity Conference

Superior Group of Companies to Participate in Noble Capital Markets' 21st Annual Emerging Growth Equity Conference GlobeNewswire December 01, 2025 ST. PETERSBURG, Fla., Dec. 01, 2025 (GLOBE NEWSWIRE) — Superior Group of Companies, Inc. (NASDAQ: SGC) today announced that Chairman and Chief Executive Officer, Michael Benstock, and President and Chief Financial Officer, Mike Koempel, will

Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire December 01, 2025 SAN CARLOS, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea” or the “Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that on November 26, 2025, the compensation committee of Biomea's board of directors

Safe Bulkers, Inc. Announces a Ten Million Shares of Common Stock Repurchase Program

Safe Bulkers, Inc. Announces a Ten Million Shares of Common Stock Repurchase Program GlobeNewswire December 01, 2025 MONACO, Dec. 01, 2025 (GLOBE NEWSWIRE) — Safe Bulkers, Inc. (the Company) (NYSE: SB), an international provider of marine drybulk transportation services, announced today that it has authorized a program under which it may from time to time

Scroll to Top